Fig. 5From: Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerizationFlow cytometric analysis of the cell cycle phases in untreated HepG2 cells (A) and HepG2 cells treated with compound 5 (0.9 µM) (B). C DNA content in the different cell cycle phases of HepG2 cellsBack to article page